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Abstract
Background: Gender-specific smoking cessation strategies have rarely been developed. Evidence of effectiveness
of physical activity (PA) promotion and intervention in adjunct to smoking cessation programs is not strong.
SPRINT study is a randomized controlled trial (RCT) designed to evaluate a counselling intervention on smoking
cessation and PA delivered to women attending the Italian National Health System Cervical Cancer Screening
Program. This paper presents study design and baseline characteristics of the study population.
Methods/Design: Among women undergoing the Pap examination in three study centres (Florence, Turin,
Mantua), participants were randomized to the smoking cessation counselling [S], the smoking cessation + PA
counselling [S + PA], or the control [C] groups. The program under evaluation is a standard brief counselling on
smoking cessation combined with a brief counselling on increasing PA, and was delivered in 2010. A questionnaire,
administered before, after 6 months and 1 year from the intervention, was used to track behavioural changes in
tobacco use and PA, and to record cessation rates in participants.
Discussion: Out of the 5,657 women undergoing the Pap examination, 1,100 participants (55% of smokers) were
randomized in 1 of the 3 study groups (363 in the S, 366 in the S + PA and 371 in the C groups). The three arms
did not differ on any demographic, PA, or tobacco-use characteristics. Recruited smokers were older, less educated
than non-participant women, more motivated to quit (33% vs.9% in the Preparation stage, p < 0.001), smoked
more cigarettes per day (12 vs.9, p < 0.001), and were more likely to have already done 1 or more quit attempts
(64% vs.50%, p < 0.001). The approach of SPRINT study appeared suitable to enrol less educated women who
usually smoke more and have more difficulties to quit.
Trial registration number: ISRCTN: ISRCTN52660565
Background
Smoking is the leading cause of death and of many dis-
eases for both men and women [1]. Since 1980, several
surveys carried out by the Italian Institute of Statistics
(ISTAT) showed a lower smoking decreasing trend in
women (from 19.2% in 1986 to 17.0% in 2009) in com-
parison to men (from 41.6% in 1986 to 29.5% in 2009),
and a younger age of initiation in girls, suggesting the
need for gender-specific tobacco control strategies [2].
The Framework Convention on Tobacco Control also
called for gender-specific prevention strategies [3]. How-
ever, these strategies, in particular on smoking cessation,
have rarely been developed, except those for pregnant
women [4], also in Italy [5].
The National Health System Cervical Cancer Screen-
ing Program (NHS-CCSP) in Italy is a beneficial setting
to deliver smoking cessation counselling to women aged
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ing is an important co-factor for the development of
cervical cancer, being human papilloma-virus (HPV) the
principal causal factor [6]. Recent studies showed a
synergistic effect between HPV-16 and smoking in the
development of cervical carcinoma in situ [7]. HPV-
positive smoking women are at higher risk of developing
cervical intraepithelial neoplasia grade III (CIN3) [8,9].
Eighty percent of sexually active women contracts the
infection up to 50 years of age [10]. Therefore, an inter-
vention to reduce smoking prevalence in women should
be a priority. In addition, women participating in
screening programs are probably more sensitive to
health promotion messages and more motivated to
adopt risk-reducing health behaviours. For these reasons
the screening settings might represent an occasion to
promote healthy lifestyles, and this primary prevention
activity might be easily integrated with the ongoing rou-
tine secondary prevention practice.
The linkage between smoking cessation and the fear to
gain weight is well documented. Women’s concern about
their weight has been hypothesized to be a factor in pre-
venting smoking cessation efforts, increasing smoking
relapse rates among quitters, and encouraging smoking
initiation. Women are more likely than men to believe
that smoking helps control body weight and are more
likely to report actually using cigarettes as a means to
control their weight [11]. Because calorie reduction may
enhance the reinforcing value of smoking, clinical prac-
tice guidelines recommended physical activity (PA),
rather than diet [4,12]. Relatively small doses of exercise
should be recommended as an aid to managing cigarette
cravings and withdrawal symptoms [13]. Physical activity
programs have been proposed as adjuncts to smoking
cessation programs and to relapse prevention programs.
However, a Cochrane review of 13 randomized con-
trolled trials examining PA as a support for smoking ces-
sation concluded that there was limited evidence that it
helped [14]. Only one of the 13 trials found evidence for
PA, in particular vigorous exercise, aiding smoking cessa-
tion at long term follow-up, with at least a delay in
weight gain [15]. All the other trials were too small to
exclude reliably an effect of intervention. There is also
preliminary indication that even moderate-intensity exer-
cise may enhance short-term smoking cessation out-
comes for women [16]. A relapse prevention intervention
showed that increased moderate to vigorous PA signifi-
cantly predicted sustained 6-month abstinence [17].
Moreover, minimal interventions strategy aimed at pro-
moting moderate/intensity PA with advice provided by
health professionals, based on the trans-theoretical
model of behavioural change [18], was effective in produ-
cing short-term increases in number of minutes walked
among inactive individuals contemplating changes in
their PA levels [19,20]. Therefore, adding a PA counsel-
ling to the standard smoking cessation counselling deliv-
ered may improve quit rates among women attending the
Pap test examination.
The SPRINT Study was designed in order to verify the
effectiveness of a standard counselling intervention on
smoking cessation delivered by trained midwives in a
gender-specific setting (the outpatient cervical cancer
screening visits), and whether the adjunct of PA coun-
selling to the standard smoking cessation counselling
might increase quit rates among women undergoing the
NHS-CCSP. This paper describes the characteristics of
the female smokers enrolled in the study in comparison
to those registered in non-participant female smokers.
Methods/Design
The SPRINT intervention
The Sprint intervention is a standard brief counselling on
smoking cessation combined with a brief counselling on
increasing PA. The smoking cessation counselling corre-
sponds to the first two phases of the brief intervention for
smoking cessation ("Ask” and “Advice”) [12]. It is tailored
according to the Di Clemente-Prochaska stage of change
on smoking behaviour [18], and it takes about 2-3 min.
The PA counselling is a brief intervention, designed and
validated by psychologists involved in the study [19]. It is a
stage-specific counselling to quit smoking, according to
the Di Clemente-Prochaska stage assessment on PA [21].
The stages of change of each participant for smoking ces-
sation and increasing PA were obtained from the study
questionnaire. Counselling on smoking cessation and PA
was delivered by trained midwives after the Pap smear.
The involved midwives were specifically trained on moti-
vational counselling on smoking cessation and increasing
PA. A self-help booklet on smoking cessation and increas-
ing PA was provided to all study participants.
Study design
IT is a three-arm randomized controlled trial. Smokers
attending the NHS-CCSP consulting rooms who decided
to participate in the study, were the units of analysis and
were randomly assigned to one of the two intervention
arms (smoking cessation counselling [S] arm, and the
smoking cessation + PA counselling [S + PA] arm) or
the control [C] arm (Figure 1).
Units and subjects
The study population, consisting of women 25-64 years
of age attending some NHS-CCSP consulting rooms, was
expected to be enrolled in three Italian areas (4 consult-
ing rooms in Florence, Tuscany, 3 in Turin, Piedmont,
and 27 in Mantua, Lombardy). Women waiting to per-
form the test were asked to fill in the study questionnaire
and, if participating in the study, the informed consent.
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Assuming a six-month cessation rate in the S + PA arm
of about 15%, and a cessation rate in the C group of
about 8% (relative risk of 1.8), with a significant level a =
0.05, and a power of 0.80, a sample size of about 430
women per arm, and about 1,300 women overall, were
estimated to be necessary to conduct the study. Cessation
rates used in the power calculation derived from a pilot
study previously conducted in one NHS-CCSP consulting
room in Florence [22]. Knowing the number of women
attending the NHS-CCSP annually in each consulting
room of the 3 study centres, the smoking prevalence in
25-64 aged women of Northern-Central Italy (around
25% [2]), and the participation rate of about 30%
observed in the above mentioned pilot study [22], we
estimated the number of participants for the 3 centres.
Selection and randomization of women
All smoking women, aged 25-64 years and attending the
NHS-CCSP consulting rooms in the study areas, irre-
spective of their health status, were eligible if they con-
sented to participate in the study. Participating women
were randomly assigned to one of the 3 arms of the
s t u d yb yt h em i d w i v e s ,u s i n gap r e d e f i n e dl i s to fc a s u a l
numbers.
Outcome assessment
Participants had to fill in a questionnaire before to per-
form the test. Questions covered demographic charac-
teristics, lifetime and current use of cigarettes, frequency
of previous quit attempts, the Fagerstrom Tolerance
Questionnaire (FTQ) [23], and intention to quit in order
to assess the Di Clemente-Prochaska stage of change for
smoking cessation [18]: from pre-contemplation phase
to preparation phase. Non-participants had not to fill in
the FTQ. In the questionnaire there were also questions
regarding physical exercises. A 5-item scale was used to
assess stage of change from sedentariness to regular and
vigorous PA [21]: a total of 5 stages were distinguished
in the questionnaire, following the Di Clemente-Pro-
chaska stage of change (precontemplation, contempla-
tion, preparation, action, or maintenance), and
according to the intention to increase or maintain the
frequency of PA at baseline PA levels (whether
Women in the waiting rooms 
attending for the Pap test, 
filled in the study 
questionnaire (n=5,647) 
Current smokers (n=2,002) 
Current smokers 
interested to participate in the study were randomized  (n=1,100) 
Smoking intervention 
(n=363) 
Smoking and physical 
activity intervention 
(n=366) 
Control intervention 
(n=371) 
Non-smokers  
or former smokers 
(n= 3,645) 
Current smokers  
not interested to 
participate in the 
study (n=902) 
Follow up at 6 months and 1 year 
Figure 1 Flow chart of the enrolment of women in the SPRINT study.
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least 30 min. on ≥ 5 days per week [24]).
A telephone follow-up to all participants was sched-
uled after six months and one year from the interven-
tion, in order to know how many women successfully
quitted after the intervention. The same questionnaire
for tobacco use and PA levels was used in the follow-up
interviews, in order to assess the Di Clemente-Prochaska
stages of change for smoking cessation and increasing
PA after the intervention. The analysis of these data are
ongoing.
Ethical aspects
The SPRINT Study was submitted and approved by the
Ethics Committee of the Local Health Authority of Flor-
ence, Italy.
Analysis
We conducted a descriptive analysis of the baseline
characteristics of non-participant female smokers vs.
recruited female smokers and across the study arms and
centres. Differences in proportions were analyzed using
the Chi-squared test. The non-parametric Mann-Whit-
ney U test was used to test for difference in continuous
variables, since data showed a non-normal distribution.
Characteristics of the enrolled population
A total of 5,647 women who underwent the Pap smear
test filled in the study questionnaire; 2,002 of them
(35.4%) were current smokers, and 1,100 of them (54.9%
of smokers) decided to participate to the study. Then,
363, 366, and 371 participants were randomly assigned
to the S, S + PA, and C arms, respectively (Figure 1).
Recruited smokers were older, less educated, more
likely to be married and employed (Table 1). Participa-
tion rate was significantly higher in Mantua (65%) than
those recorded in Florence (53%) and Turin (50%). More-
over, recruited women smoked more cigarettes per day
(12 vs. 9, p < 0.001), and were more likely to have already
done ≥ 1 quit attempts than non-participants (64% vs.
50%; p < 0.001). Finally, looking at the Di Clemente-Pro-
chaska stages of change for smoking cessation, recruited
women were more likely to be in the preparation and
contemplation stages, whereas non-participating women
were more likely to be in the precontemplation stage
(Table 1). Finally, 45% of recruited women engaged in
moderate or intense PA for at least 30 min. on ≥ 5 days
per week, 21% of participants were in the preparation
stage for increasing PA, and 45% in the action or mainte-
nance stages. Looking at the FTQ, 23% of participants
recorded high or very high nicotine dependence.
There were no significant differences among the 3
arms of the study, looking at socio-demographic, PA,
and tobacco-use variables (Table 1).
Discussion
The SPRINT Study is an Italian multicenter trial aiming
to evaluate the effectiveness of a NHS-CCSP-based
smoking cessation intervention with an additional coun-
selling on PA. It mobilizes resources from 3 regional
centres in Italy, and involved 1,100 women.
The cervical cancer screening programme represents
an opportunity to contact a large number of smoking
women: in the last years, in Italy, more than 1,500,000
women attend the initial examination (the Pap smear),
[25] and 19.6% out of them are estimated to be smokers
[26].
The three study centres (Florence, Turin, and Mantua)
recruited the expected study samples, and recorded a
participation rate from 50% in Turin to 65% in Mantua,
higher than the participation rate of 31.5% recorded in
the pilot study previously conducted [22]. This high par-
ticipation rate might be due to the high sensitivity to
smoking cessation of recruited women and, at the same
time, to the direct involvement in the study of trained
midwives of the outpatient cervical cancer screening vis-
its, meanwhile in the first pilot study the recruitment
was carried out by an health visitor in the waiting room
for the Pap test examination.
Other strengths of the study are the large sample size
and the measurement of variations from baseline stage
of self-reported behavioural change for smoking cessa-
tion and increasing PA after the intervention.
Recruited women recorded peculiar tobacco-use char-
acteristics in comparison to non-participant women:
they were more motivated to quit (about one third was
in the preparation stage), smoked more cigarettes per
day, and had already attempted to quit. Eighty-one per-
cent of smokers in the preparation stage for smoking
cessation, 64% in the contemplation stage, and only 38%
in the pre-contemplation stage participated voluntarily
to the study. Thus, this distribution by motivation level
among participants could determine an unexpectedly
high cessation rate in the control group. Anyhow, this
bias is unavoidable in intervention studies where the
intervention cannot be imposed and the subjects under
study must be necessarily volunteers.
Another limit of the study is that all the outcome
measures on smoking cessation and PA are self-
reported, even though self-reports are considered a low-
cost approach to obtaining sufficiently accurate informa-
tion on tobacco use and PA [27,28].
Regarding the motivational phase, it must be outlined
that for PA the percentage of sedentary women in pre-
contemplation (those who does not want even to think
to change their habit) is similar in recruited and in non
participant women (almost 25%); on the contrary pre-
contemplating smokers among non participants are
twice the participants (61.6% vs 30.7%). These data
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weight and at the same time the resistance to quit.
Smoking appeared to attenuate weight gain over time
and this is also a reason of female smokers’ resistance to
quit smoking, even if the average weight of women who
are current smokers is modestly lower than that of
women never smoked or who are former smokers
[4-29].
In conclusion, smoking is actually the predominant
health problem in developed countries, accounting for
about 19,000 attributable deaths in Italian women in
2010 [30]. Promoting smoking cessation in women is
one of the most important strategies to reduce female
smoking attributable mortality in next decades. In order
to meet this challenge, SPRINT trial uses a gender-spe-
cific setting to deliver smoking cessation counselling to
women, and evaluates the effectiveness of a standard
smoking cessation counselling intervention tailored to
women with an adjunct of PA counselling. Moreover,
through the study approach it was possible to enrol less
Table 1 Comparison of baseline characteristics of non-participant women vs. recruited women, by SPRINT trial arm (C:
Control arm, S: Smoking intervention, S + PA: Smoking and physical activity intervention)
Non participant
women
(n = 902)
Recruited women
(n = 1,100)
p-value C
(n = 371)
S
(n = 363)
S+P A
(n = 366)
Age (years) - mean (sd) 42 (11.8) 43 (10.8) 0.005 43 (10.3) 43 (11.2) 44 (11.0)
Education: graduated - n (%) 218 (24.2) 204 (18.5) 0.002 68 (18.3) 70 (19.3) 66 (18.0)
Marital status - n(%) 0.006
Never married 296 (32.8) 280 (25.4) 90 (24.3) 98 (27.0) 92 (25.1)
Married 471 (52.2) 616 (56.0) 219 (59.0) 194 (53.7) 202 (55.2)
Divorced/separated 105 (11.6) 163 (14.8) 49 (13.2) 58 (16.0) 56 (15.3)
Widowed 22 (2.4) 30 (2.7) 9 (2.4) 8 (2.2) 13 (3.5)
Women with children - n (%) 282 (31.3) 387 (35.2) 0.169 139 (37.5) 122 (33.6) 126 (34.4)
Employed - n (%) 600 (66.5) 773 (70.3) 0.048 258 (69.5) 258 (71.1) 257 (70.2)
Study centre - n (%) < 0.001
Florence, Tuscany 194 (47.4) 215 (52.6) 72 (19.4) 73 (20.1) 70 (19.1)
Turin, Piedmont 495 (50.3) 489 (49.7) 165 (44.5) 161 (44.3) 163 (44.5)
Mantua, Lombardy 213 (35.0) 396 (65.0) 134 (36.1) 129 (35.5) 133 (36.3)
Physical activity characteristics
30 min. of moderate/intense PA ≥ 5 days a week - n (%) 440 (48.8) 499 (45.4) 0.146 177 (47.7) 155 (42.7) 167 (45.6)
Stage - n(%) 0.318
Precontemplation/Contemplation 212 (23.5) 286(26.0) 99 (26.7) 92(25.3) 95(26.0)
Preparation 171(19.0) 227(20.6) 69(18.6) 82(22.6) 76(20.8)
Action/Maintenance 440(48.8) 499(45.4) 177(47.7) 155(42.7) 167(45.6)
Missing 79 (8.8) 88 (8.0) 26(7.0) 34(9.4) 28(7.6)
Smoking habits characteristics
Cigarettes per day - mean (sd) 9(6.3) 12 (7.1) < 0.001 13 (7.7) 12 (6.8) 12 (7.0)
≥ 20 cigarettes per day - n(%) 87 (9.6) 230 (20.9) < 0.001 87 (23.4) 71 (19.6) 72 (19.7)
Age of smoking initiation -mean (sd) 19 (5.0) 18 (5.0) 0.142 18 (6.5) 18 (4.7) 19 (5.3)
≥ 1 quit attempts - n(%) 454 (50.3) 708 (64.4) < 0.001 250 (67.4) 242 (66.7) 216 (59.0)
Stage (%) < 0.001
Precontemplation 556 (61.6) 338 (30.7) 113(30.5) 102(28.1) 123(33.6)
Contemplation 199 (22.1) 353 (32.1) 128(34.5) 110(30.3) 115(31.4)
Preparation 84 (9.3) 359 (32.6) 117(31.5) 130(35.8) 112(30.6)
Missing 63(7.0) 50(4.5) 13(3.5) 21(5.8) 16(4.4)
Fagerström Test for Nicotine Dependence
High-very high dependence - n(%) –§ 254 (23.1) 99 (26.7) 87 (24.0) 68 (18.6)
Smoking the first cigarette within 5 min. after awakening- n (%) –§ 120 (10.9) 45 (12.1) 39 (10.7) 36 (9.8)
§ Non participant women did not fill in the Fagerstrom Questionnaire
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more difficulties to quit.
Acknowledgements
We would like to extend special thanks to all enrolled women who kindly
accepted to be involved in this study, and to Mrs Simona Alberghini for the
quality control of the multicentric database.
This study was supported by the Italian Minister of Health within the
research project “Programma Integrato Oncologia 2006” (art.12 D. Lgs
no.502/1992 and ss.mm.ii.; Del GRT no.598/2007; CUP: D11J07000040001)
Author details
1Cancer Prevention and Research Institute, Florence, Italy.
2CPO Piedmont,
Turin, Italy.
3Local Health Authority, Mantua, Italy.
4Italian League against
Cancer, Florence, Italy.
5Local Health Authority, Florence, Italy.
6Unit of
Environmental and Occupational Epidemiology, Cancer Prevention and
Research Institute (ISPO), Via delle Oblate 2, 50141 Florence, Italy.
Authors’ contributions
EC conceived of the study, participated in the design of the study,
coordinated the multicentric study group and draft the manuscript. GG
participated in the design and analysis of the study, and contributed to the
manuscript draft. GC analysed the data and contributed to the manuscript
draft. LG participated in the design of the study, was responsible of the
study in Piedmont, and contributed to the manuscript draft. EA participated
in the design of the study, was responsible of the study in Lombardy, and
contributed to the manuscript draft. AI participated in the design of the
study, was responsible of the study in Tuscany, and contributed to the
manuscript draft. CB participated in the design of the study and trained the
personnel involved in recruitment. EG participated in the design of the
study, trained the personnel involved in recruitment, and revised the
manuscript. AC participated in the design of the study, carried out the study
in Piedmont and revised the manuscript. FT participated in the design of
the study, carried out the study in Lombardy and revised the manuscript.
MRG participated in the design of the study, carried out the study in
Tuscany and revised the manuscript. All authors read and approved the final
manuscript.
Author's information
The SPRINT Working Group includes the previous mentioned authors and all
the midwives who enrolled the population under study: E. Amadori (Local
Health Authority of Mantua, Italy); E. Anghinoni (Local Health Authority of
Mantua, Italy); A.M. Badiali (ISPO, Florence, Italy); B. Baldini (Local Health
Authority of Florence, Italy); B. Baluga (Local Health Authority of Mantua,
Italy); A.M. Barbi (Local Health Authority of Mantua, Italy); M.C. Barbieri (Local
Health Authority of Florence, Italy); C. Bellati (CPO, Turin, Piedmont, Italy); B.
Benatti (Local Health Authority of Mantua, Italy); E. Berini (Local Health
Authority of Mantua, Italy); L. Boldrini (Local Health Authority of Mantua,
Italy); P. Breviglieri (Local Health Authority of Mantua, Italy); C. Bronchi (Local
Health Authority of Florence, Italy); V. Cacciarini (ISPO, Florence, Italy); L.
Calabrese (Local Health Authority of Florence, Italy); L. Campitelli (Local
Health Authority of Mantua, Italy); L. Caraffa (Local Health Authority of
Mantua, Italy); N. Casoni (Local Health Authority of Mantua, Italy); G. Catelani
(Local Health Authority of Florence, Italy); D. Casi (Local Health Authority of
Florence, Italy); P. Cavini (Local Health Authority of Florence, Italy); E. Chellini
(ISPO, Florence, Italy); S. Clara (Local Health Authority of Turin, Italy); A. Cerchi
(Local Health Authority of Turin, Italy); N. Colledan (Local Health Authority of
Turin, Italy); A. Coppo (CPO, Turin, Piedmont, Italy); L. Cozzi (Local Health
Authority of Florence, Italy); C. Danielis (Local Health Authority of Mantua,
Italy); C. Di Pierro (ISPO, Florence, Italy); F. Di Stefano (CPO, Turin, Piedmont,
Italy); C. Ferrari (Local Health Authority of Mantua, Italy); M. Ferri (Local heath
Authority of Mantua, Italy); T. Ferri (Local Health Authority of Mantua, Italy); L.
Fiaccadori (Local Health Authority of Mantua, Italy); F. Florio (Local Health
Authority of Mantua, Italy); C. Forlucci (Local Health Authority of Florence,
Italy); E. Galanti (Local Health Authority of Florence, Italy; A.M. Gallina (Local
Health Authority of Mantua, Italy); M. Gialdini (Local Health Authority of
Mantua, Italy); L. Giordano (CPO, Turin, Piedmont, Italy); M.R. Giovacchini
(Local Health Authority of Florence, Italy); G. Gorini (ISPO, Florence, Italy); E.
Grechi (LILT, Florence, Italy); L. Grossi (Local Health Authority of Mantua,
Italy); S. Guzzo (Local Health Authority of Mantua, Italy); G. Innocenti (Local
Health Authority of Florence, Italy); A. Iossa (ISPO, Florence, Italy); S. Labardi
(Local Health Authority of Florence, Italy); C. Lepri (Local Health Authority of
Florence, Italy); D. Montovanelli (Local Health Authority of Mantua, Italy); G.
Mantovani (Local Health Authority of Mantua, Italy); A. Marchi (Local Health
Authority of Mantua, Italy); S. Mazzoni (Local Health Authority of Florence,
Italy); M. Molinari (Local Health Authority of Mantua, Italy); M. Morandini
(Local Health Authority of Florence, Italy); R. Nidiaci (ISPO, Florence, Italy); P.
Noli (Local Health Authority of Mantua, Italy); A.M. Notarangelo (Local Health
Authority of Turin, Italy); S. Oliveri Del Castillo (Local Health Authority of
Mantua, Italy); R. Pasini (Local Health Authority of Mantua, Italy); F. Perfetti
(Local Health Authority of Mantua, Italy); C. Prati (Local Health Authority of
Mantua, Italy); G. Pria (Local Health Authority of Mantua, Italy); S. Raffanini
(Local Health Authority of Mantua, Italy); N. Rigoni (Local Health Authority of
Mantua, Italy); E. Russo (Local Health Authority of Mantua, Italy); R. Sgarbi
(Local Health Authority of Mantua, Italy); M.E. Siliprandi (Local Health
Authority of Mantua, Italy); D. Simoncelli (Local Health Authority of Mantua,
Italy); F. Talassi (Local Health Authority of Mantua, Italy); C. Ticci (Local Health
Authority of Florence, Italy); S. Toffalini (Local Health Authority of Mantua,
Italy); C. Tovagliari (Local Health Authority of Mantua, Italy); M. Vaccari (Local
Health Authority of Mantua, Italy); C. Vair (Local Health Authority of Turin,
Italy), M. Zambello (Local Health Authority of Mantua, Italy).
Competing interests
The authors declare that they have no competing interests.
Received: 20 September 2011 Accepted: 7 December 2011
Published: 7 December 2011
References
1. International Agency for Research on Cancer (IARC): In IARC Monographs on
the Evaluation of Carcinogenic Risks to Humans. Tobacco Smoke and
Involuntary Smoking. Volume 83. Lyon; 2004.
2. Italian Institute of Statistics (ISTAT): Multipurpose Surveys 1986-2009 [http://
www.istat.it].
3. WHO: WHO Framework Convention on Tobacco Control Geneva; 2003.
4. US Department of Health and Human Services: Women and smoking: A
Report of the Surgeon General Atlanta; 2001 [http://www.surgeongeneral.
gov/library/reports/].
5. Mamme libere da fumo. [http://www.mammeliberedalfumo.org/].
6. Plummer M, Herrero R, Franceschi S, Meijer CJ, Snijders P, Bosch FX, de
Sanjosé S, Muñoz N, IARC Multi-centre Cervical Cancer Study Group:
Smoking and cervical cancer: pooled analysis of the IARC multi-centric
case-control study. Cancer Causes Control 2003, 14:805-814.
7. Gunnel AS, Tran TN, Torrang A, Dickman PW, Sparén P, Palmgren J,
Ylitalo N: Synergy between cigarette smoking and human papilloma
virus type 16 in cervical cancer in situ development. Cancer Epidemiol
Biomarkers Prev 2006, 15:2141-2147.
8. Tolstrup J, Munk C, Thomsen BL, Svare E, van den Brule AJ, Grønbaek M,
Meijer C, Kjaer Krüger S: The role of smoking and alcohol intake in the
development of high-grade squamous intraepithelial lesions among
high-risk HPV-positive women. Acta Obstet Gynecol Scand 2006,
85:1114-1119.
9. McIntyre-Seltman K, Castle PE, Guido R, Schiffman M, Wheeler CM, ALTS
Group: Smoking is a risk factor for cervical intraepithelial neoplasia
grade 3 among oncogenic human papillomavirus DNA-positive women
with equivocal or mildly abnormal cytology. Cancer Epidemiol Biomarkers
Prev 2005, 14:1165-1170.
10. Carozzi FM: Le basi biologiche dei vaccini per il papilloma virus umano.
Epidem Prev 2007, 31:92-99.
11. Amos A: Women and smoking. Br Med Bull 1996, 52:74-89.
12. AHRQ: Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice
Guideline Rockville; 2008 [http://www.ahrq.gov/path/tobacco.htm#Clinic].
13. Taylor AH, Ussher MH, Faulkner G: The acute effects of exercise on
cigarette cravings, withdrawal symptoms, affect and smoking behaviour:
a systematic review. Addiction 2007, 102(4):534-543.
14. Ussher MH, Taylor A, Faulkner G: Exercise interventions for smoking
cessation. Cochrane Database of Systematic Reviews 2008, , 4: CD002295
[http://www2.cochrane.org/reviews/en/ab002295.html].
15. Marcus BH, Albrecht AE, King TK, Parisi AF, Pinto BM, Roberts M, Niaura RS,
Abrams DB: The efficacy of exercise as an aid for smoking cessation in
Chellini et al. BMC Public Health 2011, 11:906
http://www.biomedcentral.com/1471-2458/11/906
Page 6 of 7women: a randomized controlled trial. Arch Intern Med 1999,
159(11):1229-1234.
16. Williams DM, Whiteley JA, Dunsiger S, Jennings EG, Albrecht AE, Ussher MH,
Ciccolo JT, Parisi AF, Marcus BH: Moderate intensity exercise as an adjunct
to standard smoking cessation treatment for women: a pilot study.
Psychol Addict Behav 2010, 24(2):349-354.
17. Prochaska JJ, Hall SM, Humfleet G, Munoz RF, Reus V, Gorecki J, Hu D:
Physical activity as a strategy for maintaining tobacco abstinence: a
randomized trial. Prev Med 2008, 47(2):215-220, Epub 2008 May 16.
18. Prochaska JO, Di Clemente CC: Stages and processes of self-change of
smoking: toward an integrative model of change. J Consulting Clin
Psychol 1983, 51:390-395.
19. Calfas KJ, Long BJ, Sallis JF, Wooten WJ, Pratt M, Patrick K: A controlled trial
of physician counseling to promote the adoption of physical activity.
Prev Med 1996, 25:225-233.
20. Long BJ, Calfas KJ, Wooten W, Sallis JF, Patrick K, Goldstein M, Marcus BH,
Schwenk TL, Chenoweth J, Carter R, Torres T, Palinkas LA, Heath G: A
multisite field test of the acceptability of physical activity counseling in
primary care: project PACE. Am J Prev Med 1996, 12:73-81.
21. Marcus BH, Rakowski W, Rossi JS: Assessing motivational readiness and
decision making for exercise. Health Psychol 1992, 11:257-261.
22. Chellini E, Gorini G, Gasparrini A, Grazzini G, Iossa A, Martellucci PM,
Terrone R: Cervical cancer screening visit as occasion for counselling
smoking women to quit. Tumori .
23. Fagerstrom KO: Measuring degree of physical dependence to tobacco
smoking with reference to individualization of treatment. Addict Behav
1978, 3:235-241.
24. Pate RR, Pratt M, Blair SN, Haskell WL, Macera CA, Bouchard C, Buchner D,
Ettinger W, Heath GW, King AC, Kriska A, Leon AS, Marcus BH, Morris J,
Paffenbarger RS Jr, Patrick K, Pollock ML, Rippe JM, Sallis J, Wilmore JH:
Physical activity and public health. A recommendation from the Centers
for Disease Control and Prevention and the American College of Sports
Medicine. JAMA 1995, 273:402-407.
25. I numeri degli screening. [http://www.osservatorionazionalescreening.it/ita/
i-numeri-degli-screening].
26. Rapporto annuale sul fumo 2011. [http://www.iss.it/fumo/rann/cont.php?
id=246&lang=1&tipo=3].
27. Aires N, Selmer R, Thelle D: The validity of self-reported leisure time
physical activity, and its relationship to serum cholesterol, blood
pressure and body mass index. A population based study of 332,182
men and women aged 40-42 years. Eur J Epidemiol 2003, 18:479-485.
28. Assaf AR, Parker D, Lapane KL, McKenney JL, Carleton RA: Are there gender
differences in self-reported smoking practices? Correlation with
thiocyanate and cotinine levels in smokers and nonsmokers from the
Pawtucket Heart Health Program. J Womens Health 2002, 11:899-906.
29. US Department of Health and Human Services: The Health benefits of
smoking cessation. A Report of the Surgeon General Atlanta; 1990 [http://
www.surgeongeneral.gov/library/reports/].
30. Gallus S, Muttarak R, Martinez Sanchez JM, Zuccaro P, Colombo P, La
Vecchia C: Smoking prevalence and smoking attributable mortality in
Italy, 2010. Prev Med 2011.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2458/11/906/prepub
doi:10.1186/1471-2458-11-906
Cite this article as: Chellini et al.: The Pap smear screening as an
occasion for smoking cessation and physical activity counselling:
baseline characteristics of women involved in the SPRINT randomized
controlled trial. BMC Public Health 2011 11:906.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Chellini et al. BMC Public Health 2011, 11:906
http://www.biomedcentral.com/1471-2458/11/906
Page 7 of 7